Prophylactic norepinephrine for prevention of spinal anesthesia-induced hypotension in patients aged 60 years and older: A prospective comparative study

Spinal anesthesia-induced hypotension is common in older adults and may be clinically important because age-related cardiovascular reserve and autonomic compensation are reduced. This prospective comparative interventional study evaluated the association between prophylactic norepinephrine and hypotension after spinal anesthesia in patients aged ≥ 60 years. Sixty participants undergoing lower-limb fracture surgery or abdominal hysterectomy were included, with 30 in a control group and 30 in a norepinephrine group. All Libyan participants received spinal anesthesia with 12.5 mg hyperbaric bupivacaine and 25.0 μg fentanyl. The norepinephrine protocol consisted of an 8.0 μg IV bolus followed by an 8.0 μg/min infusion. Systolic blood pressure (SBP) and heart rate were recorded at baseline and at 3, 6, 9, 14, 19, 24, 29, 34, and 39 minutes after spinal anesthesia. The primary outcome was at least one scheduled SBP measurement below 80.0% of baseline. Hypotension occurred in 22/30 control participants (73.3%) and 4/30 norepinephrine participants (13.3%). The risk ratio was 0.18 (95% CI, 0.07 - 0.46; p < 0.001), with an absolute risk reduction of 60.0 percentage points (95% CI, 25.9 - 80.5). Mean lowest SBP was 116.7 ± 12.0 mmHg in controls and 129.5 ± 10.7 mmHg in the norepinephrine group (p < 0.001), while maximum SBP decline was 20.5 ± 7.1% and 10.2 ± 6.9%, respectively (p < 0.001). Exploratory repeated-measures analysis showed a significant SBP group-by-time interaction (p = 0.037). Baseline heart rate was higher in the norepinephrine group (801 ± 6.5 vs 74.5 ± 7.4 beats/min; p = 0.003), limiting interpretation of subsequent heart-rate comparisons. No bradycardia, respiratory complication, or allergic/anaphylactic event was recorded. In this 60-participantstudy, prophylactic norepinephrine was associated with a lower incidence of prespecified hypotension during the 39-minute observation period.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-21
DOI
https://doi.org/10.5281/zenodo.24413080
Primary Topic
Anesthesia and Pain Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Prophylactic norepinephrine for prevention of spinal anesthesia-induced hypotension in patients aged 60 years and older: A prospective comparative study

Farij A. Traina
Zenodo (CERN European Organization for Nuclear Research)
Anesthesia and Pain Management
article

Prophylactic norepinephrine for prevention of spinal anesthesia-induced hypotension in patients aged 60 years and older: A prospective comparative study

Farij A. Traina
article en

Abstract

Spinal anesthesia-induced hypotension is common in older adults and may be clinically important because age-related cardiovascular reserve and autonomic compensation are reduced. This prospective comparative interventional study evaluated the association between prophylactic norepinephrine and hypotension after spinal anesthesia in patients aged ≥ 60 years. Sixty participants undergoing lower-limb fracture surgery or abdominal hysterectomy were included, with 30 in a control group and 30 in a norepinephrine group. All Libyan participants received spinal anesthesia with 12.5 mg hyperbaric bupivacaine and 25.0 μg fentanyl. The norepinephrine protocol consisted of an 8.0 μg IV bolus followed by an 8.0 μg/min infusion. Systolic blood pressure (SBP) and heart rate were recorded at baseline and at 3, 6, 9, 14, 19, 24, 29, 34, and 39 minutes after spinal anesthesia. The primary outcome was at least one scheduled SBP measurement below 80.0% of baseline. Hypotension occurred in 22/30 control participants (73.3%) and 4/30 norepinephrine participants (13.3%). The risk ratio was 0.18 (95% CI, 0.07 - 0.46; p < 0.001), with an absolute risk reduction of 60.0 percentage points (95% CI, 25.9 - 80.5). Mean lowest SBP was 116.7 ± 12.0 mmHg in controls and 129.5 ± 10.7 mmHg in the norepinephrine group (p < 0.001), while maximum SBP decline was 20.5 ± 7.1% and 10.2 ± 6.9%, respectively (p < 0.001). Exploratory repeated-measures analysis showed a significant SBP group-by-time interaction (p = 0.037). Baseline heart rate was higher in the norepinephrine group (801 ± 6.5 vs 74.5 ± 7.4 beats/min; p = 0.003), limiting interpretation of subsequent heart-rate comparisons. No bradycardia, respiratory complication, or allergic/anaphylactic event was recorded. In this 60-participantstudy, prophylactic norepinephrine was associated with a lower incidence of prespecified hypotension during the 39-minute observation period.

Zenodo (CERN European Organization for Nuclear Research)
Misurata University (LY)
Anesthesia and Pain Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Prophylactic norepinephrine for prevention of spinal anesthesia-induced hypotension in patients aged 60 years and older: A prospective comparative study — Farij A. Traina · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS